Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Current Opinion in Obstetrics & Gynecology|May 7, 2004
Immunological treatment of ovarian cancerMartin J Cannon, Alessandro D Santin, Timothy J O'BrienExpert Review of Anticancer Therapy|October 20, 2007
Advances in dendritic-cell-based therapeutic vaccines for cervical cancerStefania Bellone, Sergio Pecorelli, Martin J Cannon, et al.Expert Opinion on Biological Therapy|January 29, 2011
Dendritic cell vaccination against ovarian cancer--tipping the Treg/TH17 balance to therapeutic advantage?Martin J Cannon, Hannah Goyne, Pamela J B Stone, et al.Molecular Immunology|April 15, 2005
An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cellsMark D Crew, Martin J Cannon, Bounleut Phanavanh, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
Ovarian tumor ascites CD14+ cells suppress dendritic cell-activated CD4+ T-cell responses through IL-10 secretion and indoleamine 2,3-dioxygenaseHannah E Goyne, Pamela J B Stone, Alexander F Burnett, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
CD4+ T cell-induced differentiation of EBV-transformed lymphoblastoid cells is associated with diminished recognition by EBV-specific CD8+ cytotoxic T cellsAaruni Khanolkar, Zheng Fu, L Joey Underwood, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzymeKristina L Bondurant, Mark D Crew, Alessandro D Santin, et al.The Journal of Biological Chemistry|August 27, 2017
The glycosyltransferase GnT-III activates Notch signaling and drives stem cell expansion to promote the growth and invasion of ovarian cancerHeba Allam, Blake P Johnson, Mao Zhang, et al.Cancer Immunity|July 1, 2006
Recognition of a cervical cancer derived tumor cell line by a human papillomavirus type 16 E6 52-61-specific CD8 T cell cloneKevin H Kim, Ryan Dishongh, Alessandro D Santin, et al.Current Pharmaceutical Design|October 27, 2005
Therapeutic vaccines for cervical cancer: dendritic cell-based immunotherapyAlessandro D Santin, Stefania Bellone, Juan J Roman, et al.Pageof 6